| 000 | 01596 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515131503.0 | ||
| 264 | 0 | _c20090917 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1708-5381 | ||
| 024 | 7 |
_a10.2310/6670.2008.00030 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEagleton, Matthew J | |
| 245 | 0 | 0 |
_aCalcium channel blockers and angiotensin-converting enzyme inhibitors may be associated with altered atherosclerotic plaque size and morphology. _h[electronic resource] |
| 260 |
_bVascular _c |
||
| 300 |
_a171-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aAtherosclerosis _xchemically induced |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xtherapeutic use |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLower Extremity _xblood supply |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeripheral Vascular Diseases _xchemically induced |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aUltrasonography, Interventional _xmethods |
| 700 | 1 | _aBishop, Paul D | |
| 700 | 1 | _aBena, James F | |
| 700 | 1 | _aNassoiy, Sean P | |
| 700 | 1 | _aClair, Daniel G | |
| 700 | 1 | _aKashyap, Vikram S | |
| 700 | 1 | _aOuriel, Kenneth | |
| 773 | 0 |
_tVascular _gvol. 16 _gno. 3 _gp. 171-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2310/6670.2008.00030 _zAvailable from publisher's website |
| 999 |
_c18149759 _d18149759 |
||